4. 4
Biological importance of proteins
And
proteins function
•proteins are important for all living organisms, since they represent
the main constituent of the biological cell.
•Proteins can be hydrolyzed to their basic constituent (amino acids)
then utilized in synthesis some of target proteins like Creatinen and
Collagen in Skin, hairs and rails as well as in connective tissues.
Also, Myosin and action that used in building of muscles.
•Amino acids are utilized for synthesis of different enzymes that
involved in all biochemical processes in the living organisms.
5. 5
•Broad number of hormones of animialia kingdom or even planta
kingdom are basically protein in nature or their derivatives like
Insulin, Glocagen, Thyroxin or Adrenalin.
•Immune system depends in proteins for synthesis of antibodies
required for identification of antigens and consequently induction the
defense response.
•Proteins have a role in respiration since they participitate in synthesis
of Hemoglobin molecule that transfer O2 from lungs to different
body's parts.
•Protein transfer lipids in blood current through forming of
lipoproteins molecules.
6. 6
•Some proteins play a role in storage like ferritine protein that store
ferrous in liver.
•They have a role in pH regulation as well as a role in membrane
permeability.
•They used as source of energy in cell in some urgent cases.
•Some proteins do special functions like role of arginine in vision of
eyes.
Lastly and not the last, proteins have economic importance like;
Wool, Silk, Surgical wires or even glue that can be obtained from
heating of collagen.
7. 7
Amino Acids
The basic unit of proteins is the amino acid. In nature, there are more than 200
amino acids but there are only 20 amino acids that are involved in protein
synthesis. The main chemical structure of amino acids is occurred as follow:
8. 8
Amino Acids
Since the carbon atom of the protein is occurred in ά- position,
there are two forms of any protein levo- and Dexo- (L&D)
15. Protein structure: overview
Structural element Description
primary structure amino acid sequence of protein
secondary structure helices, sheets, turns/loops
super-secondary structure association of secondary structures
domain self-contained structural unit
tertiary structure folded structure of whole protein
• includes disulfide bonds
quaternary structure assembled complex (oligomer)
• homo-oligomeric (1 protein type)
• hetero-oligomeric (>1 type)
2-6
16. Protein structure: helices
alpha 3.10 pi
amino acids
per turn: 3.6 3.0 4.4
frequency ~97% ~3% rare
- alpha helices are about
10 residues on average
- side chains are well
staggered, preventing
steric hindrance
- helices can form
bundles, coiled coils, etc.
H-bonding
2-7
17. Protein structure: sheets
- the basic unit of a
beta-sheet is called a
beta-strand
- unlike alpha-helix, sheets
can be formed from
discontinuous regions of a
polypeptide chain
- beta-sheets can form
various higher-level
structures, such as a
beta-barrel
anti-parallel
parallel
‘twisted’
Green
Fluorescent
Protein
(GFP)
2-8
18. Protein structure: sheets (detail)
‘twisted’
- notice the difference
in H-bonding pattern
between parallel and
anti-parallel beta-sheets
- also notice orientation
of side chains relative
to the sheets
2-9
19. Protein structure: turns/loops
ribonuclease A
- there are various types of
turns, differing in the
number of residues and
H-bonding pattern
- loops are typically longer;
they are often called coils
and do not have a
‘regular’,
or repeating, structure loop
(usually exposed on surface)
alpha-helix beta-sheet
2-10
20. Protein-solvent interactions
hydrophilic amino acids (D, E, K, R, H, N, Q)
- these amino acids tend to interact extensively with solvent in
context of the folded protein; the interaction is mostly ionic and H-
bonding
- there are instances of hydrophilic residues being buried in the
interior of the protein; often, pairs of these residues form salt
bridges
hydrophobic amino acids (M, I, L, V, F, W, Y, A*, C, P)
- these tend to form the ‘core’ of the protein, i.e., are buried
within the folded protein; some hydrophobic residues can be
entirely (or partially) exposed
small neutral amino acids (G, A*, S, T)
- less preference for being solvent-exposed or not
2-13
21. The disulfide bond
protein protein
+
protein protein
• disulfide bond formation is a covalent modification; the
oxidation reaction can either be intramolecular (within the same
protein) or inter-molecular (within different proteins, e.g.,
antibody light and heavy chains). The reaction is reversible.
- most disulfide-bonded proteins are extracellular
(e.g. lysozyme contains four disulfide bonds);
the conditions inside the cytosol are reducing,
meaning that the cysteines are usually in reduced form
- cellular enzymes (protein disulfide isomerases) assist
many proteins in forming proper disulfide bond(s)
oxidation
reduction
+ 2 H+
+ 2 e-
2-14
22. Protein folding
“arguably the single most important process in biology”
in the test tube versus in the cell
~40 years ~20 years
2-15
23. Folding of RNAse A in the test tube
denaturation renaturation
Incubate protein
in guanidine
hydrochloride
(GuHCl)
or urea
100-fold
dilution of protein
into physiological
buffer
Anfinsen, CB (1973) Principles that govern the folding of protein chains.
Science 181, 223-230.
- the amino acid sequence of a polypeptide is sufficient to
specify its three-dimensional conformation
Thus: “protein folding is a spontaneous process that does not
require the assistance of extraneous factors”
(aggregation)
2-16
25. • folding can be thought
to occur along
“energy surfaces or
landscapes”
• limited number of
secondary structure
elements: helices,
sheets and turns
Protein folding theory
Dobson, CM (2001)
Phil Trans R Soc Lond
356, 133-145
2-18
26. Folding of lysozyme
• hen lysozyme has 129 residues,
consists of 2 domains (α and β)
hydrophobic collapse
- upon dilution of unfolded
protein in buffer, the protein
will ‘collapse’ onto itself,
trying to bury as many
hydrophobic surfaces as
possible
- in doing so, the protein
may fold properly, or:
- misfold and aggregate
- go through a ‘trapped
intermediate’ stage
2-19
27. Protein synthesis: the ribosome
Yusupov et al. (2001) Science 292, 883.
- whole 70S ribosome from Thermus
thermophilus at 5.5Å
- small (30S) subunit: 16S RNA, ~20
proteins
- large (50S) subunit: 23S RNA, 5S RNA,
>30 proteins
- high concentration in the cell (~ 50 μM)
2-20
28. Protein synthesis cycle
interface view of 50S subunit
E-, P-, A-site
tRNAs and mRNA
1. acylation of tRNAs with respective amino acids
2. binding of tRNA charged with methionine to P-site
on the AUG start codon (present on the mRNA)
3. next tRNA charged with appropriate amino acid
binds A-site
4. transpeptidation (peptide bond formation) between
P-site (N-terminal) amino acid and A-site amino acid
leads to the growth of the polypeptide chain. The
catalysis is by the peptidyltransferase, which consists
only of RNA. The ribosome is thus a ribozyme.
5. the E-site represents the ‘exit’ site for the
uncharged tRNA
6. release from tRNA and disassembly then occurs
2-21
29. Elongation of the polypeptide chain
adapted from Selmer et al. (1999) Science 286: 2349-2352
- PT = peptidyltransferase site
- rRNAs are in grey
- proteins are in green
- polypeptide chain model is
shown to traverse the
ribosome channel from the PT
site to the polypeptide exit site
- the channel/tunnel and exit site are quite narrow, meaning that
there is likely to be little if any co-translational protein folding
in the channel
- possibility of an alpha-helix forming? (“yes”)
2-22
30. Co-translational protein folding
folding
assembly
Fact:
- first ~30 amino acids of the polypeptide chain
present within the ribosome is constrained
(the N-terminus emerges first)
Assumption:
as soon as the nascent chain is extruded, it will start
to fold co-translationally (i.e., acquire secondary
structures, super-secondary structures, domains)
until the complete polypeptide is produced and
extruded
2-23
31. Observing co-translational folding
N-terminal
domain
(~22 kDa)
C-terminal
domain
(~40 kDa)
Experiment:
1. translate firefly luciferase RNA in vitro in the
presence of 35S-methionine for 2 min
2. Prevent re-initiation of translation with
aurintricarboxylic acid (ATCA): ‘synchronizing’
3. at set timepoints, quench translation, incubate with
proteinase K (digests unstructured/non-compact
regions in proteins, but not folded domains/proteins)
4. add denaturing (SDS) buffer, then perform SDS-
PAGE (polyacrylamide gel electrophoresis)
5. dry gel, observe by autoradiography
Firefly
Luciferase
(62 kDa)
3
Result:
4 5 6 7 8 10 12
no
ProK
with
ProK
min
60 kDa
40 kDa
20 kDa
60 kDa
40 kDa
20 kDa
2
3 4 5 6 7 8 10 12 min
2
2-24
32. Antibiotics & protein synthesis
antibiotic effect
cyclohexamide
inhibits the eukaryotic peptidyltransferase;
prevents release of the polypeptide chain. Can
be used to isolate ribosome-nascent chain
complexes
chloramphenicol inhibits the prokaryotic peptidyltransferase
puromycin
causes premature chain termination and release
from ribosome. Puromycin is similar to a
tyrosyl-tRNA and acts as a substrate during
elongation. Once added to the carboxyl end of
the nascent chain, protein synthesis is aborted
tetracycline inhibits aminoacyl tRNA binding to the A-site
kanamycin causes misreading of the mRNA
streptomycin causes misreading of the mRNA
antibiotics can be useful tools for manipulating translation, folding
2-25
33. ssrA RNA in bacteria
Solution:
- SsrA, or 10SA RNA is a small RNA (363 nt)
that resembles a tRNA and can be charged
with alanine. It is placed into the
peptidyltransferase site by the protein SsrB
- SsrA can be used as a template, and codes
a peptide, ANDENYALAA
- the fusion protein containing this sequence
is recognized and degraded by the ClpAP or
ClpPX proteases
Problem:
- turnover (degradation) of mRNA occurs
very quickly in bacteria, and the 3’ end of
the mRNA has a higher probability of being
degraded first
- if the stop codon is removed, there are no
signals for mRNA release from the
ribosome, and the mRNA will stall
2-26
34. Nascent chain stalling in eukaryotes
- can make proteins that are of a defined length by translating
an RNA that is truncated at the 3’ end (i.e., has no stop codon)
Steps:
1. linearize a vector encoding a gene of interest using a restriction
enzyme, such that the cut is precisely where you want the
polypeptide to end (before the stop codon)
2. make RNA using nucleotides and polymerase enzyme
3. add to an in vitro translation system (rabbit reticulocyte lysate),
which has all of the required components to translate the RNA
4. if the RNA is not truncated, the full-length protein will be made
and released; if the RNA is truncated, it will remain bound to the
ribosome
Note: the protein can be labeled this way with 35S-methionine;
co-translational folding still takes place
2-27
35. Chain stalling: in practice
Goal: show that firefly luciferase can adopt a folded, functional
conformation co-translationally
Experiment:
1. prepare DNA construct that encodes firefly luciferase and an extra 35
amino acids at its C-terminus
2. digest construct such that the last 2 amino acids and the stop codon are
removed
3. prepare RNA using polymerase and nucleotides
4. in vitro translate the RNA in rabbit reticulocyte lysate
5. assay for firefly luciferase activity (light emission at 560 nm occurs when
luciferin substrate is oxidatively decarboxylated)
Fact: only full-length firefly luciferase is functional
Problem? Hint: does this experiment show physiological relevance?
2-28
36. Protein folding:
in 3 different environments
• ex vivo refolding rabbit reticulocyte lysate
- rabbit reticulocyte lysate is an abundant source of molecular
chaperones, many of which are ATP-dependent
• in vitro folding environments
- protein folding (from denaturant), when possible, requires the
proper environment:
proper pH, salts, concentration of protein, temperature,
stabilizing agents (e.g., other proteins, glycerol, etc.)
• in vivo folding
- molecular chaperones, protein folding catalysts, proper redox
environment, availability of binding partners
2-29
37. Following the acquisition
of (native) structure
denaturation renaturation native
structure?
• regain of 2º, 3º and 4º structures
- by circular dichroism and
fluorescence measurements
- by other criteria (e.g., native gel
electrophoresis, SEC,
protease sensitivity assays, etc.)
• regain of activity
- activity not necessarily enzymatic
Circular
dichroism
unfolding
refolding
2-30
38. Acquisition of native structure:
examples
• actin
- chemically denatured actin can be refolded by incubating it in
rabbit reticulocyte lysate; native gel electrophoresis, and
binding to DNAse I is used to assess folding
• various small proteins (RNAse A, lysozyme, etc.)
- can be denatured chemically and refolded simply by dilution
of the denaturing agent; activity assays are available, but
folding can be monitored using spectroscopic techniques
• other
- small-angle light x-ray scattering (SAXS), NMR are some
other techniques used to monitor protein folding
2-31
39. Protein denaturants
• high temperatures
- cause protein unfolding, aggregation
• low temperatures
- some proteins are sensitive to cold denaturation
• heavy metals (e.g., lead, cadmium, etc.)
- highly toxic; efficiently induce the ‘stress response’
• proteotoxic agents (e.g., alcohols, cross-linking agents, etc.)
• oxygen radicals, ionizing radiation
- cause permanent protein damage
• chaotropes (urea, guanidine hydrochloride, etc.)
- highly potent at denaturing proteins;
often used in protein folding studies
2-32
40. Following the loss of structure
• loss of secondary structure
- the far-UV circular dichroism spectrum of a protein changes
at the so-called ‘melting temperature’ or Tm
- fluorescence characteristics will likely also change
• loss of tertiary structure
- the far- and near-UV circular dichroism spectra of a protein
change, but the Tm of both spectra may be different
- fluorescence characteristics will likely also change
• loss of activity
- the activity of a protein can be monitored over time
• aggregation
- can measure light scattering (e.g., at 320 nm) spectrophoto-
metrically, or by detecting the protein in a precipitate
2-33
41. Loss of structure: example
folded
unfolded
intermediate
Far-UV
spectrum
Fluorescence
spectrum
Noland et al. (1999) Biochemistry 38, 16136.
native
unfolded
2M
urea
Urea (M)
chymotrypsin
0
no
0
Yes
1
Yes
2
Yes
Bacterial luciferase (α subunit)
2-34
42. 42
See you in the next lecture
With my best wishes
THANK YOU
Dr. Aysam Fayed
